Global Human Vaccine Market Insights and Forecast to 2028

Report ID: 1542582 | Published Date: Jan 2025 | No. of Page: 129 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Varicella
        1.2.3 Influenza
        1.2.4 Polio
        1.2.5 Hepatitis A
        1.2.6 Rabies
        1.2.7 BCG
        1.2.8 Hepatitis B
        1.2.9 Pertussis, Diphtheria, Tetanus
        1.2.10 Pneumococcal
        1.2.11 Rota vaccine
    1.3 Market by Application
        1.3.1 Global Human Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adults
        1.3.3 Children
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Vaccine Sales by Region
        2.4.1 Global Human Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Human Vaccine by Region (2023-2028)
    2.5 Global Human Vaccine Revenue by Region
        2.5.1 Global Human Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Human Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Vaccine Sales by Manufacturers
        3.1.1 Global Top Human Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Vaccine in 2021
    3.2 Global Human Vaccine Revenue by Manufacturers
        3.2.1 Global Human Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Vaccine Revenue in 2021
    3.3 Global Human Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Vaccine Sales by Type
        4.1.1 Global Human Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Human Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Human Vaccine Revenue by Type
        4.2.1 Global Human Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Human Vaccine Price by Type
        4.3.1 Global Human Vaccine Price by Type (2017-2022)
        4.3.2 Global Human Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Vaccine Sales by Application
        5.1.1 Global Human Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Human Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Human Vaccine Revenue by Application
        5.2.1 Global Human Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Human Vaccine Price by Application
        5.3.1 Global Human Vaccine Price by Application (2017-2022)
        5.3.2 Global Human Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Vaccine Market Size by Type
        6.1.1 North America Human Vaccine Sales by Type (2017-2028)
        6.1.2 North America Human Vaccine Revenue by Type (2017-2028)
    6.2 North America Human Vaccine Market Size by Application
        6.2.1 North America Human Vaccine Sales by Application (2017-2028)
        6.2.2 North America Human Vaccine Revenue by Application (2017-2028)
    6.3 North America Human Vaccine Market Size by Country
        6.3.1 North America Human Vaccine Sales by Country (2017-2028)
        6.3.2 North America Human Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Vaccine Market Size by Type
        7.1.1 Europe Human Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Human Vaccine Revenue by Type (2017-2028)
    7.2 Europe Human Vaccine Market Size by Application
        7.2.1 Europe Human Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Human Vaccine Revenue by Application (2017-2028)
    7.3 Europe Human Vaccine Market Size by Country
        7.3.1 Europe Human Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Human Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Vaccine Market Size by Type
        8.1.1 Asia Pacific Human Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Vaccine Market Size by Application
        8.2.1 Asia Pacific Human Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Vaccine Market Size by Region
        8.3.1 Asia Pacific Human Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Vaccine Market Size by Type
        9.1.1 Latin America Human Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Human Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Human Vaccine Market Size by Application
        9.2.1 Latin America Human Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Human Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Human Vaccine Market Size by Country
        9.3.1 Latin America Human Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Human Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Vaccine Market Size by Type
        10.1.1 Middle East and Africa Human Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Vaccine Market Size by Application
        10.2.1 Middle East and Africa Human Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Vaccine Market Size by Country
        10.3.1 Middle East and Africa Human Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CNBG
        11.1.1 CNBG Corporation Information
        11.1.2 CNBG Overview
        11.1.3 CNBG Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CNBG Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CNBG Recent Developments
    11.2 Changsheng Life
        11.2.1 Changsheng Life Corporation Information
        11.2.2 Changsheng Life Overview
        11.2.3 Changsheng Life Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Changsheng Life Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Changsheng Life Recent Developments
    11.3 Zhifei
        11.3.1 Zhifei Corporation Information
        11.3.2 Zhifei Overview
        11.3.3 Zhifei Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Zhifei Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Zhifei Recent Developments
    11.4 ChengDa Bio
        11.4.1 ChengDa Bio Corporation Information
        11.4.2 ChengDa Bio Overview
        11.4.3 ChengDa Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 ChengDa Bio Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 ChengDa Bio Recent Developments
    11.5 Kangtai
        11.5.1 Kangtai Corporation Information
        11.5.2 Kangtai Overview
        11.5.3 Kangtai Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Kangtai Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Kangtai Recent Developments
    11.6 SINOVAC BIOTECH
        11.6.1 SINOVAC BIOTECH Corporation Information
        11.6.2 SINOVAC BIOTECH Overview
        11.6.3 SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 SINOVAC BIOTECH Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 SINOVAC BIOTECH Recent Developments
    11.7 Hissen
        11.7.1 Hissen Corporation Information
        11.7.2 Hissen Overview
        11.7.3 Hissen Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Hissen Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hissen Recent Developments
    11.8 Walvax Biotechnology
        11.8.1 Walvax Biotechnology Corporation Information
        11.8.2 Walvax Biotechnology Overview
        11.8.3 Walvax Biotechnology Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Walvax Biotechnology Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Walvax Biotechnology Recent Developments
    11.9 GSK
        11.9.1 GSK Corporation Information
        11.9.2 GSK Overview
        11.9.3 GSK Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 GSK Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 GSK Recent Developments
    11.10 SANOFI
        11.10.1 SANOFI Corporation Information
        11.10.2 SANOFI Overview
        11.10.3 SANOFI Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 SANOFI Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 SANOFI Recent Developments
    11.11 Rong An
        11.11.1 Rong An Corporation Information
        11.11.2 Rong An Overview
        11.11.3 Rong An Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Rong An Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Rong An Recent Developments
    11.12 NuoCheng Bio
        11.12.1 NuoCheng Bio Corporation Information
        11.12.2 NuoCheng Bio Overview
        11.12.3 NuoCheng Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 NuoCheng Bio Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 NuoCheng Bio Recent Developments
    11.13 Hualan Bio
        11.13.1 Hualan Bio Corporation Information
        11.13.2 Hualan Bio Overview
        11.13.3 Hualan Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Hualan Bio Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Hualan Bio Recent Developments
    11.14 Tiantan biological
        11.14.1 Tiantan biological Corporation Information
        11.14.2 Tiantan biological Overview
        11.14.3 Tiantan biological Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Tiantan biological Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Tiantan biological Recent Developments
    11.15 Changchun Baike
        11.15.1 Changchun Baike Corporation Information
        11.15.2 Changchun Baike Overview
        11.15.3 Changchun Baike Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Changchun Baike Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Changchun Baike Recent Developments
    11.16 Adimmune
        11.16.1 Adimmune Corporation Information
        11.16.2 Adimmune Overview
        11.16.3 Adimmune Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Adimmune Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Adimmune Recent Developments
    11.17 Zhongyianke Biotech
        11.17.1 Zhongyianke Biotech Corporation Information
        11.17.2 Zhongyianke Biotech Overview
        11.17.3 Zhongyianke Biotech Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Zhongyianke Biotech Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Zhongyianke Biotech Recent Developments
    11.18 Bharat Biotech
        11.18.1 Bharat Biotech Corporation Information
        11.18.2 Bharat Biotech Overview
        11.18.3 Bharat Biotech Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Bharat Biotech Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Bharat Biotech Recent Developments
    11.19 Bavarian Nordic
        11.19.1 Bavarian Nordic Corporation Information
        11.19.2 Bavarian Nordic Overview
        11.19.3 Bavarian Nordic Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Bavarian Nordic Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Bavarian Nordic Recent Developments
    11.20 Sanofi-Pasteur
        11.20.1 Sanofi-Pasteur Corporation Information
        11.20.2 Sanofi-Pasteur Overview
        11.20.3 Sanofi-Pasteur Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.20.4 Sanofi-Pasteur Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Sanofi-Pasteur Recent Developments
    11.21 Indian Immunologicals
        11.21.1 Indian Immunologicals Corporation Information
        11.21.2 Indian Immunologicals Overview
        11.21.3 Indian Immunologicals Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.21.4 Indian Immunologicals Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.21.5 Indian Immunologicals Recent Developments
    11.22 KANGH
        11.22.1 KANGH Corporation Information
        11.22.2 KANGH Overview
        11.22.3 KANGH Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.22.4 KANGH Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.22.5 KANGH Recent Developments
    11.23 Henan Grand Biopharma
        11.23.1 Henan Grand Biopharma Corporation Information
        11.23.2 Henan Grand Biopharma Overview
        11.23.3 Henan Grand Biopharma Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.23.4 Henan Grand Biopharma Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.23.5 Henan Grand Biopharma Recent Developments
    11.24 ZhongKe Biopharm
        11.24.1 ZhongKe Biopharm Corporation Information
        11.24.2 ZhongKe Biopharm Overview
        11.24.3 ZhongKe Biopharm Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.24.4 ZhongKe Biopharm Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.24.5 ZhongKe Biopharm Recent Developments
    11.25 Zhuoyi Biological
        11.25.1 Zhuoyi Biological Corporation Information
        11.25.2 Zhuoyi Biological Overview
        11.25.3 Zhuoyi Biological Human Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.25.4 Zhuoyi Biological Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.25.5 Zhuoyi Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Vaccine Industry Chain Analysis
    12.2 Human Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Vaccine Production Mode & Process
    12.4 Human Vaccine Sales and Marketing
        12.4.1 Human Vaccine Sales Channels
        12.4.2 Human Vaccine Distributors
    12.5 Human Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Vaccine Industry Trends
    13.2 Human Vaccine Market Drivers
    13.3 Human Vaccine Market Challenges
    13.4 Human Vaccine Market Restraints
14 Key Findings in The Global Human Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Varicella
    Table 3. Major Manufacturers of Influenza
    Table 4. Major Manufacturers of Polio
    Table 5. Major Manufacturers of Hepatitis A
    Table 6. Major Manufacturers of Rabies
    Table 7. Major Manufacturers of BCG
    Table 8. Major Manufacturers of Hepatitis B
    Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus
    Table 10. Major Manufacturers of Pneumococcal
    Table 11. Major Manufacturers of Rota vaccine
    Table 12. Global Human Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 13. Global Human Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 14. Global Human Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 15. Global Human Vaccine Sales Market Share by Region (2017-2022)
    Table 16. Global Human Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 17. Global Human Vaccine Sales Market Share by Region (2023-2028)
    Table 18. Global Human Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 19. Global Human Vaccine Revenue Market Share by Region (2017-2022)
    Table 20. Global Human Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 21. Global Human Vaccine Revenue Market Share by Region (2023-2028)
    Table 22. Global Human Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
    Table 23. Global Human Vaccine Sales Share by Manufacturers (2017-2022)
    Table 24. Global Human Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 25. Global Human Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 26. Human Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 27. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 28. Global Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2021)
    Table 29. Human Vaccine Manufacturing Base Distribution and Headquarters
    Table 30. Manufacturers Human Vaccine Product Offered
    Table 31. Date of Manufacturers Enter into Human Vaccine Market
    Table 32. Mergers & Acquisitions, Expansion Plans
    Table 33. Global Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 34. Global Human Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 35. Global Human Vaccine Sales Share by Type (2017-2022)
    Table 36. Global Human Vaccine Sales Share by Type (2023-2028)
    Table 37. Global Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 38. Global Human Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 39. Global Human Vaccine Revenue Share by Type (2017-2022)
    Table 40. Global Human Vaccine Revenue Share by Type (2023-2028)
    Table 41. Human Vaccine Price by Type (2017-2022) & (USD/Dose)
    Table 42. Global Human Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 43. Global Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 44. Global Human Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 45. Global Human Vaccine Sales Share by Application (2017-2022)
    Table 46. Global Human Vaccine Sales Share by Application (2023-2028)
    Table 47. Global Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 48. Global Human Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 49. Global Human Vaccine Revenue Share by Application (2017-2022)
    Table 50. Global Human Vaccine Revenue Share by Application (2023-2028)
    Table 51. Human Vaccine Price by Application (2017-2022) & (USD/Dose)
    Table 52. Global Human Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 53. North America Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 54. North America Human Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 55. North America Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 56. North America Human Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 57. North America Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 58. North America Human Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 59. North America Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 60. North America Human Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 61. North America Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 62. North America Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 63. North America Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 64. North America Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 65. Europe Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 66. Europe Human Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 67. Europe Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 68. Europe Human Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 69. Europe Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 70. Europe Human Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 71. Europe Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 72. Europe Human Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 73. Europe Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 74. Europe Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 75. Europe Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 76. Europe Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 78. Asia Pacific Human Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 79. Asia Pacific Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Human Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 82. Asia Pacific Human Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 83. Asia Pacific Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Human Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 85. Asia Pacific Human Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 86. Asia Pacific Human Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 87. Asia Pacific Human Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 88. Asia Pacific Human Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 89. Latin America Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 90. Latin America Human Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 91. Latin America Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 92. Latin America Human Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 93. Latin America Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 94. Latin America Human Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 95. Latin America Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 96. Latin America Human Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 97. Latin America Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 98. Latin America Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 99. Latin America Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 100. Latin America Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Human Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Human Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 106. Middle East and Africa Human Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 107. Middle East and Africa Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Human Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 109. Middle East and Africa Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 110. Middle East and Africa Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 111. Middle East and Africa Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 112. Middle East and Africa Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 113. CNBG Corporation Information
    Table 114. CNBG Description and Major Businesses
    Table 115. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 116. CNBG Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. CNBG Recent Developments
    Table 118. Changsheng Life Corporation Information
    Table 119. Changsheng Life Description and Major Businesses
    Table 120. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 121. Changsheng Life Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Changsheng Life Recent Developments
    Table 123. Zhifei Corporation Information
    Table 124. Zhifei Description and Major Businesses
    Table 125. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 126. Zhifei Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Zhifei Recent Developments
    Table 128. ChengDa Bio Corporation Information
    Table 129. ChengDa Bio Description and Major Businesses
    Table 130. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 131. ChengDa Bio Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. ChengDa Bio Recent Developments
    Table 133. Kangtai Corporation Information
    Table 134. Kangtai Description and Major Businesses
    Table 135. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 136. Kangtai Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Kangtai Recent Developments
    Table 138. SINOVAC BIOTECH Corporation Information
    Table 139. SINOVAC BIOTECH Description and Major Businesses
    Table 140. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 141. SINOVAC BIOTECH Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. SINOVAC BIOTECH Recent Developments
    Table 143. Hissen Corporation Information
    Table 144. Hissen Description and Major Businesses
    Table 145. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 146. Hissen Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Hissen Recent Developments
    Table 148. Walvax Biotechnology Corporation Information
    Table 149. Walvax Biotechnology Description and Major Businesses
    Table 150. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 151. Walvax Biotechnology Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Walvax Biotechnology Recent Developments
    Table 153. GSK Corporation Information
    Table 154. GSK Description and Major Businesses
    Table 155. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 156. GSK Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. GSK Recent Developments
    Table 158. SANOFI Corporation Information
    Table 159. SANOFI Description and Major Businesses
    Table 160. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 161. SANOFI Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. SANOFI Recent Developments
    Table 163. Rong An Corporation Information
    Table 164. Rong An Description and Major Businesses
    Table 165. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 166. Rong An Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Rong An Recent Developments
    Table 168. NuoCheng Bio Corporation Information
    Table 169. NuoCheng Bio Description and Major Businesses
    Table 170. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 171. NuoCheng Bio Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. NuoCheng Bio Recent Developments
    Table 173. Hualan Bio Corporation Information
    Table 174. Hualan Bio Description and Major Businesses
    Table 175. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 176. Hualan Bio Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Hualan Bio Recent Developments
    Table 178. Tiantan biological Corporation Information
    Table 179. Tiantan biological Description and Major Businesses
    Table 180. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 181. Tiantan biological Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Tiantan biological Recent Developments
    Table 183. Changchun Baike Corporation Information
    Table 184. Changchun Baike Description and Major Businesses
    Table 185. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 186. Changchun Baike Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Changchun Baike Recent Developments
    Table 188. Adimmune Corporation Information
    Table 189. Adimmune Description and Major Businesses
    Table 190. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 191. Adimmune Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Adimmune Recent Developments
    Table 193. Zhongyianke Biotech Corporation Information
    Table 194. Zhongyianke Biotech Description and Major Businesses
    Table 195. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 196. Zhongyianke Biotech Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Zhongyianke Biotech Recent Developments
    Table 198. Bharat Biotech Corporation Information
    Table 199. Bharat Biotech Description and Major Businesses
    Table 200. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 201. Bharat Biotech Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Bharat Biotech Recent Developments
    Table 203. Bavarian Nordic Corporation Information
    Table 204. Bavarian Nordic Description and Major Businesses
    Table 205. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 206. Bavarian Nordic Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. Bavarian Nordic Recent Developments
    Table 208. Sanofi-Pasteur Corporation Information
    Table 209. Sanofi-Pasteur Description and Major Businesses
    Table 210. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 211. Sanofi-Pasteur Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 212. Sanofi-Pasteur Recent Developments
    Table 213. Indian Immunologicals Corporation Information
    Table 214. Indian Immunologicals Description and Major Businesses
    Table 215. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 216. Indian Immunologicals Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 217. Indian Immunologicals Recent Developments
    Table 218. KANGH Corporation Information
    Table 219. KANGH Description and Major Businesses
    Table 220. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 221. KANGH Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 222. KANGH Recent Developments
    Table 223. Henan Grand Biopharma Corporation Information
    Table 224. Henan Grand Biopharma Description and Major Businesses
    Table 225. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 226. Henan Grand Biopharma Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 227. Henan Grand Biopharma Recent Developments
    Table 228. ZhongKe Biopharm Corporation Information
    Table 229. ZhongKe Biopharm Description and Major Businesses
    Table 230. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 231. ZhongKe Biopharm Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 232. ZhongKe Biopharm Recent Developments
    Table 233. Zhuoyi Biological Corporation Information
    Table 234. Zhuoyi Biological Description and Major Businesses
    Table 235. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 236. Zhuoyi Biological Human Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 237. Zhuoyi Biological Recent Developments
    Table 238. Key Raw Materials Lists
    Table 239. Raw Materials Key Suppliers Lists
    Table 240. Human Vaccine Distributors List
    Table 241. Human Vaccine Customers List
    Table 242. Human Vaccine Market Trends
    Table 243. Human Vaccine Market Drivers
    Table 244. Human Vaccine Market Challenges
    Table 245. Human Vaccine Market Restraints
    Table 246. Research Programs/Design for This Report
    Table 247. Key Data Information from Secondary Sources
    Table 248. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Vaccine Product Picture
    Figure 3. Global Human Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Varicella Product Picture
    Figure 4. Influenza Product Picture
    Figure 5. Polio Product Picture
    Figure 6. Hepatitis A Product Picture
    Figure 7. Rabies Product Picture
    Figure 8. BCG Product Picture
    Figure 9. Hepatitis B Product Picture
    Figure 10. Pertussis, Diphtheria, Tetanus Product Picture
    Figure 11. Pneumococcal Product Picture
    Figure 12. Rota vaccine Product Picture
    Figure 13. Global Human Vaccine Market Share by Application in 2021 & 2028
    Figure 14. Adults
    Figure 15. Children
    Figure 16. Human Vaccine Report Years Considered
    Figure 17. Global Human Vaccine Sales 2017-2028 (M Doses)
    Figure 18. Global Human Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Human Vaccine Revenue 2017-2028 (US$ Million)
    Figure 20. Global Human Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 21. Global Human Vaccine Sales Market Share by Region (2017-2022)
    Figure 22. Global Human Vaccine Sales Market Share by Region (2023-2028)
    Figure 23. North America Human Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 24. North America Human Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Human Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 26. Europe Human Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Human Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 28. Asia-Pacific Human Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Latin America Human Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 30. Latin America Human Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Middle East & Africa Human Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 32. Middle East & Africa Human Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. The Human Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 34. The Top 5 and 10 Largest Manufacturers of Human Vaccine in the World: Market Share by Human Vaccine Revenue in 2021
    Figure 35. Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 36. Global Human Vaccine Sales Market Share by Type (2017-2028)
    Figure 37. Global Human Vaccine Revenue Market Share by Type (2017-2028)
    Figure 38. Global Human Vaccine Sales Market Share by Application (2017-2028)
    Figure 39. Global Human Vaccine Revenue Market Share by Application (2017-2028)
    Figure 40. North America Human Vaccine Sales Market Share by Type (2017-2028)
    Figure 41. North America Human Vaccine Revenue Market Share by Type (2017-2028)
    Figure 42. North America Human Vaccine Sales Market Share by Application (2017-2028)
    Figure 43. North America Human Vaccine Revenue Market Share by Application (2017-2028)
    Figure 44. North America Human Vaccine Sales Share by Country (2017-2028)
    Figure 45. North America Human Vaccine Revenue Share by Country (2017-2028)
    Figure 46. U.S. Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 47. Canada Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. Europe Human Vaccine Sales Market Share by Type (2017-2028)
    Figure 49. Europe Human Vaccine Revenue Market Share by Type (2017-2028)
    Figure 50. Europe Human Vaccine Sales Market Share by Application (2017-2028)
    Figure 51. Europe Human Vaccine Revenue Market Share by Application (2017-2028)
    Figure 52. Europe Human Vaccine Sales Share by Country (2017-2028)
    Figure 53. Europe Human Vaccine Revenue Share by Country (2017-2028)
    Figure 54. Germany Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 55. France Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 56. U.K. Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 57. Italy Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 58. Russia Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Asia Pacific Human Vaccine Sales Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Human Vaccine Revenue Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Human Vaccine Sales Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Human Vaccine Revenue Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Human Vaccine Sales Share by Region (2017-2028)
    Figure 64. Asia Pacific Human Vaccine Revenue Share by Region (2017-2028)
    Figure 65. China Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Japan Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. South Korea Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. India Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 69. Australia Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 70. Taiwan Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 71. Indonesia Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 72. Thailand Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 73. Malaysia Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Philippines Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Latin America Human Vaccine Sales Market Share by Type (2017-2028)
    Figure 76. Latin America Human Vaccine Revenue Market Share by Type (2017-2028)
    Figure 77. Latin America Human Vaccine Sales Market Share by Application (2017-2028)
    Figure 78. Latin America Human Vaccine Revenue Market Share by Application (2017-2028)
    Figure 79. Latin America Human Vaccine Sales Share by Country (2017-2028)
    Figure 80. Latin America Human Vaccine Revenue Share by Country (2017-2028)
    Figure 81. Mexico Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 82. Brazil Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. Argentina Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa Human Vaccine Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Human Vaccine Revenue Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Human Vaccine Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Human Vaccine Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Human Vaccine Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa Human Vaccine Revenue Share by Country (2017-2028)
    Figure 90. Turkey Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 92. U.A.E Human Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 93. Human Vaccine Value Chain
    Figure 94. Human Vaccine Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Frequently Asked Questions
Human Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hydraulic Pumps

Hydraulic Pumps market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More